424.91MMarket Cap-939P/E (TTM)
7.150High6.890Low624.20KVolume7.150Open7.220Pre Close4.36MTurnover1.29%Turnover RatioLossP/E (Static)61.05MShares28.26052wk High0.68P/B336.44MFloat Cap6.89052wk Low--Dividend TTM48.34MShs Float195.970Historical High--Div YieldTTM3.60%Amplitude6.890Historical Low6.983Avg Price1Lot Size
Sage Therapeutics Stock Forum
My research and analysis are not advice or recommendations. It's for information and knowledge purposes only. Any research , analysis, information, or other material received should not be construed as individualized investment advice. Investment decisions should be made as part of financial ...
oooooo
Gapping up
$Salesforce (CRM.US)$ jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected. Goldman Sachs subsequently hiked its price target by $15 to $340 a share, suggestions 58% upside.
$UBS Group (UBS.US)$ popp...
follow for daily watchlist 🚀
Great entry point. As long as it is approved and on the market, it will be open for off-label use for MDD if someone really wants it.
No comment yet